| HOME >> BIOLOGY >> TECHNOLOGY |
A lawsuit has been filed alleging that the DePuy ASR hip replacement was defectively designed and that DePuy did not timely warn surgeons and patients of the high failure rate of the device.
(PRWEB) June 15, 2010 -- A lawsuit has been filed against hip replacement manufacturer DePuy Orthopaedics, Inc over failure of a DePuy ASR metal-on-metal hip replacement. The lawsuit against DePuy was filed in Federal District Court in Ft. Myers, Florida last week. This is believed to be the first lawsuit filed in the United States over the failure of the DePuy ASR hip replacement. The patient in the suit is represented by an alliance of law firms pursuing claims on behalf of patients across the nation with failed DePuy ASR hip replacements.
The lawsuit alleges that the DePuy ASR hip replacement was defectively designed. It claims DePuy knew that their ASR hip replacements were failing at a higher than expected rate, yet it did not pass that information on to consumers or orthopaedic surgeons. As a result, diagnosis that the ASR hip replacement implanted in the patient has failed was needlessly delayed as her physicians were unaware of the prevelance of other failures. During the patient’s surgery to replace the failed hip replacement, her orthopedic surgeon discovered that the cup portion of the ASR hip replacement was extremely loose. The ASR hip replacement is designed so that a patient’s bone grows into the back of the cup to secure it. However, loosening because of a lack of bone in-growth into the cup is a hallmark of DePuy ASR hip replacement failures.
In March of this year, the New York Times published an article about the high early failure rate of DePuy’s ASR hip replacement. Since that article was published many more reports of failures of ASR hip replacements have been received by both DePuy and the United States Food and Drug Administration. In its article,
'/>"/>
| Source: PRWeb Copyright©2010 Vocus, Inc. All rights reserved |
Related biology technology :
1. Huiheng Medical, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
2. FirstAidWarehouse.co.uk Examines High Blood Pressure, or Hypertension, and Blood Pressure Monitors
3. YM BioSciences enrolls first US patient in Phase II randomized, double-blind brain metastases trial for nimotuzumab
4. Concord Medical Announces First Quarter 2010 Financial Results
5. t2cure First Company to Have Quality of Cellular Therapeutic Certified by EMA
6. Launch of GenoCon: First-ever Contest in Rational Genome Design Based on Semantic-web Technology
7. China BCT Reports First Quarter 2010 Results
8. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
9. First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers
10. AMT Provides Business Update for the First Quarter 2010
11. Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire PRESTIGE(TM) Pressure Guide Wire
 |
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |